Systematic analysis of epigenetic modifications across the entire genome in FSHD1 and FSHD2 patients will be crucial to dissect epigenetic mechanisms acting specifically on D4Z4 locus and involved in FSHD pathogenesis and progression. The gene discussed is SMCHD1; the disease is facioscapulohumeral muscular dystrophy.